Recent Finacing
Recent Raise
Novadip Biosciences develops a 3D adipose‑derived stem‑cell extracellular matrix platform producing autologous and room‑temperature allogeneic grafts for reconstructing critical‑size bone defects, spinal fusion, and non‑union fractures.
